Apixaban


( Last Updated : September 25, 2012)
Generic Name:
Apixaban
Project Status:
Complete
Therapeutic Area:
Thromboembolic events prevention, (atrial fibrillation)
Manufacturer:
Bristol-Myers Squibb Canada and Pfizer Canada Inc. Alliance
Call for patient/clinician input open:
Brand Name:
Eliquis
Project Line:
Reimbursement Review
Project Number:
SR0288-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC

Details


Submission Type:
Initial
Indications:
Thromboembolic events prevention, (atrial fibrillation)
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: